| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.26 | 0.04 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.33 | 0.04 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.04 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.31 | 0.05 |